D1 Dopamine receptors mediate neuroleptic-induced fos expression in the islands of Calleja

Synapse

Volumn 28, Issue 2, 1998, Pages 154-159

  Wirtshafter, David ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

A 77636; Atypical neuroleptics; Clozapine; Immediate early genes; Raclopride; SKF 38393

Indexed keywords

3 (1 ADAMANTYL) 1 AMINOMETHYL 3,4 DIHYDRO 5,6 DIHYDROXY 1H 2 BENZOPYRAN; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 (4 HYDROXYPHENYL) 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CLOZAPINE; DOPAMINE 1 RECEPTOR; RACLOPRIDE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ADAMANTANE; ANTIPARKINSON AGENT; BENZAZEPINE DERIVATIVE; BENZOPYRAN DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; NEUROLEPTIC AGENT; PROTEIN C FOS; SALICYLAMIDE DERIVATIVE; SK&F 82958;

ANIMAL TISSUE; ARTICLE; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PSYCHOSIS; RAT; ANIMAL; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECT; METABOLISM; OLFACTORY SYSTEM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ADAMANTANE; ANIMALS; ANTIPARKINSON AGENTS; ANTIPSYCHOTIC AGENTS; BENZAZEPINES; BENZOPYRANS; CLOZAPINE; DOPAMINE AGONISTS; MALE; OLFACTORY PATHWAYS; PROTO-ONCOGENE PROTEINS C-FOS; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; SALICYLAMIDES;

EID: 0031594263     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199802)28:2<154::AID-SYN5>3.0.CO;2-A     Document Type: Article

References (43)

1. Asin, K.E., and Wirtshafter, D. (1993) Effects of repeated dopamine D1 receptor stimulation on rotation and c-Fos expression. Eur. J. Pharmacol., 235:167-168.
2. Bischoff, S., Heinrich, M., Sonntag, J.M., and Krauss, J. (1986) The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5HT2) receptors. Eur. J. Pharmacol., 129:367-370.
3. Cenci, M.A., Campbell, K., Wictorin, K., and Bjorklund, A. (1992) Striatal c-fos induction by cocaine or apomorphine occurs preferentially in output neurons projecting to the substantia nigra in the rat. Eur. J. Neurosci., 4:376-380.
4. Deutch, A.Y., and Duman, R.S. (1996) The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: Cellular localization and pharmacological characterization. Neuroscience, 70:377-389.
5. Deutsch, A.Y., Ongur, D., and Duman, R.S. (1995) Antipsychotic drugs induce Fos protein in the thalamic paraventricular nucleus: A novel locus of antipsychotic drug action. Neuroscience, 66:337-346.
6. Dragunow, M., Robertson, G.S., Faull, R.L.M., Robertson, H.A., and Jansen, K. (1990) D2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons. Neuroscience, 37:287-294.
7. Fallon, J.H. (1983) The islands of Calleja complex of rat basal forebrain. III: Histochemical evidence for a striatopallidal system. J. Comp. Neurol., 218:91-120.
8. Fallen, J.H., Riley, J.N., Sipe, J.C., and Moore, R.Y. (1978) The islands of Calleja: Organization and connections. J. Comp. Neurol., 181:375-395.
9. Glavin, G.B. (1989) The antisecretory effects of clozapine, a dopamine D4 receptor antagonist, are blocked by the dopamine D1 receptor antagonist, SCH 23390. Life Sci., 56:365-368.
10. Graybiel, A.M., Moratalla, R., and Robertson, H.A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA, 87:6912-6916.
11. Guo, N., Klitenick, M.A., Than, C.-S., and Fibiger, H.C. (1995) Receptor mechanisms mediating clozapine-induced c-fos expression in the forebrain. Neuroscience, 65:747-756.
12. Hosoya, Y. (1973) Electron microscopic observations of the granule cells (Calleja's islands) in the olfactory tubercle of rats. Brain Res., 54:330-334.
13. Hurley, M.J., Stubbs, C.M., Jenner, P., and Marsden, C.D. (1996) Dopamine D3 receptor drugs are not involved in the induction of c-fos mRNA by neuroleptic drugs: Comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neuroleptics. Eur. J. Pharmacol., 318:283-293.
14. Imperato, A., Obinu, M.C., Carta, G., Mascia, M.S., Casu, M.A., Dazzi, L., and Cessa, G.L. (1994) Neuroleptics cause stimulation of dopamine D1 receptors and their desensitization after chronic treatment. Eur. J. Pharmacol., 264:55-60.
15. Kebabian, J.W., Britton, D.R., DeNinno, M.P., Ferner, R., Smith, L., Jenner, P., Schoenleber, R., and Williams, M.W. (1992) A-77636: A potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets. Eur. J. Pharmacol., 229:203-209.
16. Kohler, C., Hall, H., Ogren, S.O., and Gawell, L. (1985) Specific binding of 3H-raclopride, a potent substituted benzamide drug with high affinity for dopamine D2 receptors in the rat brain. In vivo and in vitro studies. Biochem. Pharmacol., 34:2251-2259.
17. LaHoste, G.J., Yu, J., and Marshall, J.F. (1993) Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc. Natl. Acad. Sci. USA, 90:7451-7455.
18. Landwehrmeyer, B., Mengod, G., and Palacios, J.M. (1993) Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur. J. Neurosci., 5:145-153.
19. MacGibbon, G.A., Lawlor, P.A., Bravo, R., and Dragunow, M. (1994) Clozapine and haloperidol produce differential patterns of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Mol. Brain Res., 23:21-32.
20. Meyer, G., Gonzalez-Hernandez, T., Carrillo-Padilla, F., and Ferres-Torres, R. (1989) Aggregations of granule cells in the basal forebrain (islands of Calleja): Golgi and cytoarchitectonic study in different mammals, including man. J. Comp. Neurol., 284:405-428.
21. Miller, J.C. (1990) Induction of c-fos mRNA expression in the striatum by neuroleptic drugs. J. Neurochem., 54:11453-1455.
22. Mulhouse, O.E. (1987) Granule cells of the olfactory tubercle and the question of the islands of Calleja. J. Comp. Neurol., 265:1-24.
23. Moratalla, R., Xu, M., Tonegawa, S., and Graybiel, A. (1996) Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc. Natl. Acad. Sci. USA, 93:14928-14933.
24. Murray, A.M., Ryoo, H.L., Gurevich, E., and Joyce, J.N. (1994) Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of the human forebrain. Proc. Natl. Acad. Sci. USA, 91:11271-11275.
25. O'Boyle, K.M., Gaitanopoulos, D.E., Brenner, M., and Waddington, J.L. (1989) Agonist and antagonist properties of benzazepine and thienopyridine derivatives at D1 dopamine receptor. Neuropharmacology, 28:401-405.
26. Ogren, S.O., Hall, H., Magnusson, O., and Sjostrand, S.E. (1986) The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions. Psychopharmacology (Berlin), 90:287-294.
27. Palacios, G., Muro, M.A., and Marin, A.P. (1996) Differential effects of haloperidol and two anxiolytic drugs, buspirone and lesopitron, on c-Fos expression in rat striatum and nucleus accumbens. Brain Res., 742:141-148.
28. Paxinos, G., and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
29. Ribak, C.E., and Fallon, J.H. (1982) The islands of Calleja complex of rat basal forebrain. I. Light and electron microscopic observations. J. Comp. Neurol., 205:207-218.
30. Robertson, G.S., Vincent, S.R., and Fibiger, H.C. (1992) D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopalldal neurons. Neuroscience, 49:285-296.
31. Robertson, H.A., Paul, M.L., Moratalla, R., and Graybiel, A.M. (1991) Expression of the immediate early gene c-fos in the basal ganglia: Induction by dopaminergic drugs. Can. J. Neurol. Sci., 18:380-383.
32. Roth, R.H., and Elsworth, J.D. (1995) Biochemical pharmacology of midbrain dopamine neurons. In: Psychopharmacology: The Fourth Generation of Progress. F. Bloom and D. Kupfer, eds. Raven Press, New York. pp. 227-244.
33. Ruskin, D.N., and Marshall, J.F. (1994) Amphetamine and cocaine-induced Fos in the rat striatum depends on D2 dopamine receptor activation. Synapse, 18:233-240.
34. Salmi, P., and Ahlenius, S. (1996) Further evidence for clozapine as a dopamine D1 receptor agonist. Eur. J. Pharmacol., 307:27-31.
35. Salmi, P., Jiminez, P., and Ahlenius, S. (1993) Evidence for specific involvement of dopamine D1 and D2 receptors in the regulation of body temperature in the rat. Eur. J. Pharmacol., 236:395-400.
36. Talbot, K., Woolf, N.J., and Butcher, L.L. (1988) Feline islands of Calleja complex: I. Cytoarchitectural organization and comparative anatomy. J. Comp. Neurol., 274:553-579.
37. Vahid-Ansari, F., and Robertson, G.S. (1996) 7-OH-DPAT differentially reverses clozapine and haloperidol-induced increases in Fos-like immunoreactivity in the rodent forebrain. Eur. J. Neurosci., 8:2605-2611.
38. Wang, J.Q., and McGinty, J.F. (1996) Scopolamine augments c-fos and Zif/286 messenger RNA expression induced by the full D1 dopamine receptor agonist SKF-82958 in the intact rat striatum. Neuroscience, 72:601-616.
39. Wirtshafter, D. (1996) Haloperidol and clozapine induce Fos-like immunoreactivity in the primate basal ganglia. Soc. Neurosci. Abstr., 22:1087.
40. Wirtshafter, D., and Asin, K.E. (1994) Interactive effects of stimulation of D1 and D2 receptors on Fos like immunoreactivity in the normosensitive rat striatum. Brain Res. Bull., 35:85-91.
41. Wirtshafter, D., and Asin, K.E. (1995) Dopamine antagonists induce Fos-like-immunoreactivity in the substantia nigra and entopeduncular nucleus of the rat. Brain Res., 70:205-214.
42. Wirtshafter, D., Asin, K.E., and Pitzer, M.A. (1994) Dopamine agonists and stress produce different patterns of Fos-like immunoreactivity in the lateral habenula. Brain Res., 633:21-26.
43. Young, S.T., Porrino, L.J., and Ladarola, M.J. (1991) Cocaine induces striatal c-Fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. USA, 88:1291-1295.